<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "journalpublishing.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="2.0" xml:lang="en" article-type="letter"><front><journal-meta><journal-id journal-id-type="nlm-ta">JMIR Dermatol</journal-id><journal-id journal-id-type="publisher-id">derma</journal-id><journal-id journal-id-type="index">29</journal-id><journal-title>JMIR Dermatology</journal-title><abbrev-journal-title>JMIR Dermatol</abbrev-journal-title><issn pub-type="epub">2562-0959</issn><publisher><publisher-name>JMIR Publications</publisher-name><publisher-loc>Toronto, Canada</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">v9i1e80679</article-id><article-id pub-id-type="doi">10.2196/80679</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Letter</subject></subj-group></article-categories><title-group><article-title>Patient Perceptions of Climate Change Impacts on Atopic Dermatitis: Cross-Sectional Survey Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Mattson</surname><given-names>Gunnar</given-names></name><degrees>MPH, MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Coates</surname><given-names>Sarah</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Twigg</surname><given-names>Amanda R</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><institution>School of Medicine, University of California, San Francisco</institution><addr-line>San Francisco</addr-line><addr-line>CA</addr-line><country>United States</country></aff><aff id="aff2"><institution>Department of Dermatology, University of California, San Francisco</institution><addr-line>1701 Divisadero Street, Third Floor</addr-line><addr-line>San Francisco</addr-line><addr-line>CA</addr-line><country>United States</country></aff><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Parker</surname><given-names>Eva</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name name-style="western"><surname>Nnajiofor</surname><given-names>Chisom</given-names></name></contrib><contrib contrib-type="reviewer"><name name-style="western"><surname>Volkman</surname><given-names>Julie</given-names></name></contrib></contrib-group><author-notes><corresp>Correspondence to Amanda R Twigg, MD, Department of Dermatology, University of California, San Francisco, 1701 Divisadero Street, Third Floor, San Francisco, CA, 94115, United States, 1 415-353-7800; <email>amanda.twigg@ucsf.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>20</day><month>1</month><year>2026</year></pub-date><volume>9</volume><elocation-id>e80679</elocation-id><history><date date-type="received"><day>15</day><month>07</month><year>2025</year></date><date date-type="rev-recd"><day>01</day><month>10</month><year>2025</year></date><date date-type="accepted"><day>01</day><month>01</month><year>2026</year></date></history><copyright-statement>&#x00A9; Gunnar Mattson, Sarah Coates, Amanda R Twigg. Originally published in JMIR Dermatology (<ext-link ext-link-type="uri" xlink:href="http://derma.jmir.org">http://derma.jmir.org</ext-link>), 20.1.2026. </copyright-statement><copyright-year>2026</copyright-year><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Dermatology, is properly cited. The complete bibliographic information, a link to the original publication on <ext-link ext-link-type="uri" xlink:href="http://derma.jmir.org">http://derma.jmir.org</ext-link>, as well as this copyright and license information must be included.</p></license><self-uri xlink:type="simple" xlink:href="https://derma.jmir.org/2026/1/e80679"/><abstract><p>This cross-sectional survey study (63.5% response rate) characterized how patients with atopic dermatitis (AD) perceive and experience the effects of climate change on their AD. Most participants reported that environmental factors such as heat and air pollution worsened their AD and expressed a desire for climate-health education, yet few had discussed these concerns with their dermatologist. These findings reveal a gap in patient-centered dermatologic care and support the development of tools to integrate environmental health into atopic dermatitis management.</p></abstract><kwd-group><kwd>atopic dermatitis</kwd><kwd>eczema</kwd><kwd>climate change dermatology</kwd><kwd>climate change</kwd><kwd>environmental health</kwd><kwd>climate health impacts</kwd><kwd>patient experience</kwd><kwd>survey study</kwd><kwd>health communication</kwd><kwd>patient education</kwd></kwd-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Climate change is recognized as the foremost global health threat of the 21st century [<xref ref-type="bibr" rid="ref1">1</xref>]. Environmental shifts (rising temperatures, air pollution, and extreme weather) can impair the skin barrier, alter the microbiome, and induce inflammation, increasing the prevalence and severity of atopic dermatitis (AD) among other skin conditions [<xref ref-type="bibr" rid="ref2">2</xref>,<xref ref-type="bibr" rid="ref3">3</xref>]. Among dermatologists, 79.6% agree it affects their patients [<xref ref-type="bibr" rid="ref4">4</xref>]. Yet, few routinely discuss this with patients, and limited research explores how patients perceive and experience these impacts. To address these gaps, this cross-sectional study surveyed patients with AD to assess how they perceive climate change&#x2019;s impact on their condition and whether these concerns are addressed in dermatologic care.</p></sec><sec id="s2" sec-type="methods"><title>Methods</title><sec id="s2-1"><title>Survey Instrument Development</title><p>The survey was informed by climate-health literature, dermatologic environmental impacts, and health communication frameworks (eg, message framing, perceived susceptibility, and severity from the Health Belief Model) [<xref ref-type="bibr" rid="ref5">5</xref>]. Five UCSF (University of California, San Francisco) dermatologists reviewed the instrument for clinical relevance and clarity. Ten adult AD patients piloted it, and feedback informed wording and usability.</p></sec><sec id="s2-2"><title>Study Population &#x0026; Recruitment</title><p>Eligible participants were English-speaking adults with AD seen at UCSF dermatology clinics between August 2023 and August 2024. A total of 2164 patients were identified by the electronic health record (EHR) query. To reduce selection bias, patients were contacted via EHR messaging or mailed letters to account for differences in digital health access; 326 patients expressed interest and became the study population. These patients were sent the study description and a secure Qualtrics link to the online survey.</p></sec><sec id="s2-3"><title>Statistical Analysis</title><p>Descriptive statistics using Microsoft Excel were used to summarize participant demographics and survey responses. Frequencies were calculated for categorical variables. No inferential or hypothesis testing was conducted, as the study aimed to characterize trends and patient-reported experiences rather than test associations or determine causality.</p></sec><sec id="s2-4"><title>Ethical Considerations</title><p>This study received exempt certification from the UCSF medical ethical review committee (IRB 21&#x2010;33538). All participants provided consent to participate in the study, and their responses were deidentified.</p></sec></sec><sec id="s3" sec-type="results"><title>Results</title><p>Of 326 individuals, 207 completed the survey (63.5% response rate). A majority of individuals (n=166/207, 80.2%, 95% CI 74.8%&#x2010;85.6%) reported that environmental-climate factors impact their AD, particularly extreme heat (n=157, 75.8%, 95% CI 70.0%&#x2010;81.7%) and poor air quality (n=81, 39.1%, 95% CI 32.5%&#x2010;45.8%). Commonly reported effects included increased medication use (n=168, 81.2%, 95% CI 75.8%&#x2010;86.5%), more symptomatic flares (n=167, 80.7%, 95% CI 75.3%&#x2010;86.1%), more skin affected (n=139, 67.1%; 95% CI 60.8%&#x2010;73.5%), and changes to daily behaviors (n=130, 62.8%; 95% CI 56.2%&#x2010;69.4%). Most participants (n=179, 86.5%; 95% CI 81.8%&#x2010;91.1%) expressed interest in understanding how environmental-climate factors affect their AD, yet only 76 participants (36.7%; 95% CI 30.1%&#x2010;43.3%) said their dermatologist addressed these concerns. The most valued strategies for addressing climate-health impacts included more information (n=164, 79.2%; 95% CI 73.7%&#x2010;84.8%), dedicated time during visits to plan for exposures (n=105, 50.7%; 95% CI 43.9%&#x2010;57.5%), and more in-person visits (n=101, 48.8%; 95% CI 42.0%&#x2010;55.6%). <xref ref-type="table" rid="table1">Table 1</xref> shows participant characteristics, and <xref ref-type="table" rid="table2">Table 2</xref> shows survey response data.</p><table-wrap id="t1" position="float"><label>Table 1.</label><caption><p>Participant demographics and background information.</p></caption><table id="table1" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Demographics</td><td align="left" valign="bottom">Participants (N=207)</td></tr></thead><tbody><tr><td align="left" valign="bottom">Age in years (mean, SD)</td><td align="left" valign="bottom">46.4 (18.6)</td></tr><tr><td align="left" valign="top" colspan="2">Sex, n (%)</td></tr><tr><td align="left" valign="top">&#x2003;Male</td><td align="left" valign="top">75 (36.2)</td></tr><tr><td align="left" valign="top">&#x2003;Female</td><td align="left" valign="top">129 (62.3)</td></tr><tr><td align="left" valign="top">&#x2003;Nonbinary</td><td align="left" valign="top">3 (1.4)</td></tr><tr><td align="left" valign="top" colspan="2">Race/Ethnicity, n (%)</td></tr><tr><td align="left" valign="top">&#x2003;American Indian or Alaskan Native</td><td align="left" valign="top">2 (1.0)</td></tr><tr><td align="left" valign="top">&#x2003;Asian or Asian American</td><td align="left" valign="top">82 (39.6)</td></tr><tr><td align="left" valign="top">&#x2003;Black or African American</td><td align="left" valign="top">12 (5.8)</td></tr><tr><td align="left" valign="top">&#x2003;Hispanic or Latino</td><td align="left" valign="top">12 (5.8)</td></tr><tr><td align="left" valign="top">&#x2003;Native Hawaiian or Pacific Islander</td><td align="left" valign="top">1 (0.5)</td></tr><tr><td align="left" valign="top">&#x2003;White</td><td align="left" valign="top">107 (51.7)</td></tr><tr><td align="left" valign="top">&#x2003;Other</td><td align="left" valign="top">5 (2.4)</td></tr><tr><td align="left" valign="top">Years living with atopic dermatitis (mean, SD)</td><td align="left" valign="top">21.6 (18.3)</td></tr><tr><td align="left" valign="top" colspan="2">Treatments used for atopic dermatitis, n (%)</td></tr><tr><td align="left" valign="top">&#x2003;Topical steroid</td><td align="left" valign="top">193 (93.7)</td></tr><tr><td align="left" valign="top">&#x2003;Topical medication other than a steroid</td><td align="left" valign="top">145 (70.4)</td></tr><tr><td align="left" valign="top">&#x2003;Topical over the counter product (does not require a prescription)</td><td align="left" valign="top">139 (67.4)</td></tr><tr><td align="left" valign="top">&#x2003;Pill medication (eg, methotrexate, cellcept, tofacitinib, upadacitinib)</td><td align="left" valign="top">47 (22.8)</td></tr><tr><td align="left" valign="top">&#x2003;Injection medication (eg, dupilumab, tralokinumab)</td><td align="left" valign="top">94 (45.6)</td></tr><tr><td align="left" valign="top">&#x2003;Phototherapy</td><td align="left" valign="top">41 (19.9)</td></tr></tbody></table></table-wrap><table-wrap id="t2" position="float"><label>Table 2.</label><caption><p>Responses to survey questions using the 5-point Likert scale, where 1 indicates &#x201C;Strongly disagree,&#x201D; 2 &#x201C;Somewhat disagree,&#x201D; 3 &#x201C;Neutral,&#x201D; 4 &#x201C;Somewhat agree,&#x201D; and 5 &#x201C;Strongly agree.&#x201D; A reported mean greater than 3 indicates agreement and less than 3 indicates disagreement.</p></caption><table id="table2" frame="hsides" rules="groups"><thead><tr><td align="left" valign="bottom">Statement, agreement ranked using the 5-point Likert scale</td><td align="left" valign="bottom">Score, mean (SD)</td></tr></thead><tbody><tr><td align="left" valign="top">Climate and environmental factors have impacted your experience with eczema</td><td align="left" valign="top">4.2 (1.0)</td></tr><tr><td align="left" valign="top" colspan="2"><named-content content-type="indent">&#x00A0;&#x00A0;&#x00A0;&#x00A0;</named-content>The following factor has impacted your experience with eczema:</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Extreme Heat</td><td align="left" valign="top">4.2 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Wildfires</td><td align="left" valign="top">3.3 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Poor Air Quality</td><td align="left" valign="top">3.4 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Drought</td><td align="left" valign="top">3.2 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Extreme Rainfall</td><td align="left" valign="top">3.0 (1.3)</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Sea Level Rise</td><td align="left" valign="top">2.4 (1.0)</td></tr><tr><td align="left" valign="top">&#x2003;&#x2003;Flooding</td><td align="left" valign="top">2.6 (1.1)</td></tr><tr><td align="left" valign="top" colspan="2">Climate and environmental factors&#x2019; impact on your eczema include:</td></tr><tr><td align="left" valign="top">&#x2003;More symptomatic with exacerbations or flares</td><td align="left" valign="top">4.2 (1.0)</td></tr><tr><td align="left" valign="top">&#x2003;More skin affected</td><td align="left" valign="top">3.9 (1.2)</td></tr><tr><td align="left" valign="top">&#x2003;Need for extra appointments with healthcare team</td><td align="left" valign="top">3.1 (1.2)</td></tr><tr><td align="left" valign="top">&#x2003;Sending additional messages to dermatologist or calling their office</td><td align="left" valign="top">3.0 (1.2)</td></tr><tr><td align="left" valign="top">&#x2003;Using medication more often</td><td align="left" valign="top">4.1 (1.0)</td></tr><tr><td align="left" valign="top">&#x2003;Change to your medication</td><td align="left" valign="top">3.2 (1.3)</td></tr><tr><td align="left" valign="top">&#x2003;Change to lifestyle or daily behaviors</td><td align="left" valign="top">3.8 (1.1)</td></tr><tr><td align="left" valign="top">You want to know how the climate and environment impact your eczema</td><td align="left" valign="top">4.2 (1.0)</td></tr><tr><td align="left" valign="top">Your dermatologist has talked about how the climate and environment affect your eczema</td><td align="left" valign="top">2.9 (1.3)</td></tr><tr><td align="left" valign="top" colspan="2">This strategy would be helpful in managing changes to your eczema from the climate and environment:</td></tr><tr><td align="left" valign="top">&#x2003;More visits in person</td><td align="left" valign="top">3.4 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;More telehealth visits</td><td align="left" valign="top">3.2 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;Time during visits to make plans for climate or environmental problems</td><td align="left" valign="top">3.5 (1.1)</td></tr><tr><td align="left" valign="top">&#x2003;More information on the topic</td><td align="left" valign="top">4.1 (0.9)</td></tr><tr><td align="left" valign="top">&#x2003;Support groups</td><td align="left" valign="top">2.9 (1.1)</td></tr></tbody></table></table-wrap></sec><sec id="s4" sec-type="discussion"><title>Discussion</title><sec id="s4-1"><title>Principal Findings</title><p>While this study does not evaluate clinical causality, it provides novel insight into how patients perceive and experience the effects of environmental-climate factors on their AD. Most participants perceived climate-related changes in their AD and desired clinical guidance, yet few reported receiving it. These findings suggest that dermatologists should initiate brief conversations about common triggers, particularly heat and air pollution, and provide anticipatory guidance and resources. This insight underscores previously reported low self-efficacy among dermatologists in discussing climate change with patients [<xref ref-type="bibr" rid="ref4">4</xref>]. Understanding these patient insights is vital to providing patient-centered care and forming effective partnerships with patients about their skin health. These efforts align with the American Academy of Dermatology&#x2019;s commitment to &#x201C;educate our patients about the effects of climate change on the health of their skin.&#x201D; [<xref ref-type="bibr" rid="ref6">6</xref>]</p></sec><sec id="s4-2"><title>Limitations and Future Direction</title><p>Limitations include a single-center design limiting generalizability, reliance on self-reported data with potential recall bias, and possible self-selection bias, as patients more affected by climate change may have been more likely to participate. Future research should validate these findings in broader populations, explore climate-health experiences in other skin conditions, and develop educational and clinical strategies to help navigate these climate-health conversations with patients. Even in short visits, dermatologists can explore patient experiences with climate change using supportive prompts (eg, &#x201C;Would it be helpful to discuss how environmental factors might relate to your flares?&#x201D;) to validate patient concerns and provide opportunities for personalized climate-health conversations to be continued in subsequent visits.</p></sec><sec id="s4-3"><title>Conclusions</title><p>This study highlights a disconnect between how patients with AD experience climate-related triggers and how often these concerns are addressed in clinical care. Findings underscore the need for tools and strategies to support climate-health conversations in dermatology. Integrating environmental health into AD management can enhance patient-centered care, improve outcomes, and reinforce dermatology&#x2019;s role at the intersection of clinical care, public health, and patient advocacy.</p></sec></sec></body><back><notes><sec><title>Data Availability</title><p>The datasets generated or analyzed during this study are available from the corresponding author on reasonable request.</p></sec></notes><fn-group><fn fn-type="conflict"><p>None declared.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term id="abb1">AD</term><def><p>atopic dermatitis</p></def></def-item><def-item><term id="abb2">EHR</term><def><p>electronic health record</p></def></def-item><def-item><term id="abb3">UCSF</term><def><p>University of California, San Francisco</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="ref1"><label>1</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watts</surname><given-names>N</given-names> </name><name name-style="western"><surname>Amann</surname><given-names>M</given-names> </name><name name-style="western"><surname>Arnell</surname><given-names>N</given-names> </name><etal/></person-group><article-title>The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises</article-title><source>Lancet</source><year>2021</year><month>01</month><day>9</day><volume>397</volume><issue>10269</issue><fpage>129</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)32290-X</pub-id><pub-id pub-id-type="medline">33278353</pub-id></nlm-citation></ref><ref id="ref2"><label>2</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mieczkowska</surname><given-names>K</given-names> </name><name name-style="western"><surname>Stringer</surname><given-names>T</given-names> </name><name name-style="western"><surname>Barbieri</surname><given-names>JS</given-names> </name><name name-style="western"><surname>Williams</surname><given-names>M</given-names> </name><name name-style="western"><surname>Rosenbach</surname><given-names>M</given-names> </name></person-group><article-title>Surveying the attitudes of dermatologists regarding climate change</article-title><source>Br J Dermatol</source><year>2022</year><month>04</month><volume>186</volume><issue>4</issue><fpage>748</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1111/bjd.20900</pub-id><pub-id pub-id-type="medline">34787308</pub-id></nlm-citation></ref><ref id="ref3"><label>3</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahn</surname><given-names>K</given-names> </name></person-group><article-title>The role of air pollutants in atopic dermatitis</article-title><source>J Allergy Clin Immunol</source><year>2014</year><month>11</month><volume>134</volume><issue>5</issue><fpage>993</fpage><lpage>999</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2014.09.023</pub-id><pub-id pub-id-type="medline">25439225</pub-id></nlm-citation></ref><ref id="ref4"><label>4</label><nlm-citation citation-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celebi Sozener</surname><given-names>Z</given-names> </name><name name-style="western"><surname>Ozdel Ozturk</surname><given-names>B</given-names> </name><name name-style="western"><surname>Cerci</surname><given-names>P</given-names> </name><etal/></person-group><article-title>Epithelial barrier hypothesis: effect of the external exposome on the microbiome and epithelial barriers in allergic disease</article-title><source>Allergy</source><year>2022</year><month>05</month><volume>77</volume><issue>5</issue><fpage>1418</fpage><lpage>1449</lpage><pub-id pub-id-type="doi">10.1111/all.15240</pub-id><pub-id pub-id-type="medline">35108405</pub-id></nlm-citation></ref><ref id="ref5"><label>5</label><nlm-citation citation-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Alyafei</surname><given-names>A</given-names> </name><name name-style="western"><surname>Easton-Carr</surname><given-names>R</given-names> </name></person-group><article-title>The health belief model of behavior change</article-title><source>StatPearls [Internet]</source><year>2025</year><access-date>2025-03-30</access-date><publisher-name>StatPearls Publishing</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK606120">https://www.ncbi.nlm.nih.gov/books/NBK606120</ext-link></comment></nlm-citation></ref><ref id="ref6"><label>6</label><nlm-citation citation-type="web"><article-title>Position Statement on Climate and Health</article-title><source>American Academy of Dermatology</source><year>2018</year><access-date>2024-03-31</access-date><comment><ext-link ext-link-type="uri" xlink:href="https://server.aad.org/forms/policies/Uploads/PS/PS%20-%20Climate%20and%20Health.pdf">https://server.aad.org/forms/policies/Uploads/PS/PS%20-%20Climate%20and%20Health.pdf</ext-link></comment></nlm-citation></ref></ref-list></back></article>